[go: up one dir, main page]

YU47524B - Postupak za izolovanje faktora viii iz drugih proteina u krvnoj plazmi - Google Patents

Postupak za izolovanje faktora viii iz drugih proteina u krvnoj plazmi

Info

Publication number
YU47524B
YU47524B YU210590A YU210590A YU47524B YU 47524 B YU47524 B YU 47524B YU 210590 A YU210590 A YU 210590A YU 210590 A YU210590 A YU 210590A YU 47524 B YU47524 B YU 47524B
Authority
YU
Yugoslavia
Prior art keywords
blood plasma
factor viii
proteins
isolation
procedure
Prior art date
Application number
YU210590A
Other languages
English (en)
Other versions
YU210590A (sh
Inventor
P. Kaersgaard
Original Assignee
Novo Nordisk A/S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/S. filed Critical Novo Nordisk A/S.
Priority to SI9012105A priority Critical patent/SI9012105A/sl
Priority to HRP-2105/90A priority patent/HRP930277A2/hr
Publication of YU210590A publication Critical patent/YU210590A/sh
Publication of YU47524B publication Critical patent/YU47524B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Networks Using Active Elements (AREA)
  • Cephalosporin Compounds (AREA)
  • Amplifiers (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Housing For Livestock And Birds (AREA)
  • External Artificial Organs (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Separation By Low-Temperature Treatments (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

POSTUPAK ZA IZOLOVANJE FAKTORA VIII IZ DRUGIH PROTEINA U KRVNOJ PLAZMI, upotrebom gel filtracije, naznačen time, što je krvna plazma podvrgnuta gel filtraciji pod uslovima grupne separacije koristeći veliko punjenje i velike protočne brzine i što je sredstvo gel filtracije sastavljeno od čestica inertnih za Faktor VIII, veličine u intervalu od oko 31 mm do oko 200 mm i opsega deljenja na frakcije u intervalu od 1 x 103 do 1 x 108. Prijava sadrži još 7 zavisnih zahteva.
YU210590A 1989-11-09 1990-11-07 Postupak za izolovanje faktora viii iz drugih proteina u krvnoj plazmi YU47524B (sh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SI9012105A SI9012105A (sl) 1989-11-09 1990-11-07 Postopek za izoliranje biološko aktivnih spoji
HRP-2105/90A HRP930277A2 (en) 1989-11-09 1993-03-08 A method for isolating biologically active compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK562189A DK162233C (da) 1989-11-09 1989-11-09 Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii

Publications (2)

Publication Number Publication Date
YU210590A YU210590A (sh) 1993-05-28
YU47524B true YU47524B (sh) 1995-10-03

Family

ID=8144000

Family Applications (1)

Application Number Title Priority Date Filing Date
YU210590A YU47524B (sh) 1989-11-09 1990-11-07 Postupak za izolovanje faktora viii iz drugih proteina u krvnoj plazmi

Country Status (26)

Country Link
US (1) US5245014A (sh)
EP (1) EP0524172B1 (sh)
JP (1) JP2509407B2 (sh)
CN (1) CN1044121C (sh)
AT (1) ATE118508T1 (sh)
AU (1) AU631471B2 (sh)
BG (1) BG61231B1 (sh)
CA (1) CA2073012C (sh)
CZ (1) CZ537190A3 (sh)
DE (1) DE69017050T2 (sh)
DK (1) DK162233C (sh)
ES (1) ES2068404T3 (sh)
FI (1) FI103510B (sh)
HU (1) HU214905B (sh)
IE (1) IE66836B1 (sh)
IL (1) IL96277A (sh)
NO (1) NO180741C (sh)
NZ (1) NZ236004A (sh)
PL (1) PL164894B1 (sh)
PT (1) PT95830B (sh)
RU (1) RU2055593C1 (sh)
SK (1) SK278640B6 (sh)
UA (1) UA29421C2 (sh)
WO (1) WO1991007438A1 (sh)
YU (1) YU47524B (sh)
ZA (1) ZA908599B (sh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042138T3 (es) * 1989-05-24 1993-12-01 Miles Inc. Filtracion en gel del factor viii tratado termicamente.
US5859204A (en) * 1992-04-07 1999-01-12 Emory University Modified factor VIII
US5888974A (en) * 1992-04-07 1999-03-30 Emory University Hybrid human/animal factor VIII
US6180371B1 (en) 1996-06-26 2001-01-30 Emory University Modified factor VIII
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
US6458563B1 (en) 1996-06-26 2002-10-01 Emory University Modified factor VIII
US7560107B2 (en) 1996-06-26 2009-07-14 Emory University Modified factor VIII
US6531577B1 (en) * 1997-12-15 2003-03-11 Hemasure Denmark A/S von Willebrand factor (vWF)-containing preparation, process for preparing vWF-containing preparations, and use of such preparations
US6290527B1 (en) * 1998-07-03 2001-09-18 Nippon Telegraph And Telephone Corp. Nippon telegraph and telephone corporation
CA2634674A1 (en) 1999-02-22 2000-08-24 Baxter International Inc. Novel albumin-free factor viii formulations
JP2002348300A (ja) * 1999-04-12 2002-12-04 Fujimori Kogyo Co Ltd 血液凝固第ｖｉｉｉ因子および血液凝固第ｖｉｉｉ因子／フォン・ビルブラント因子複合体の精製方法
AUPR638801A0 (en) * 2001-07-13 2001-08-09 Life Therapeutics Limited Factor viii separation
DK1750733T3 (da) 2004-05-03 2014-01-20 Univ Emory FREMGANGSMÅDE TIL INDGIVELSE AF SVINE-B-DOMÆNELØS fVIII
JP2008510476A (ja) * 2004-08-27 2008-04-10 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 生物学的材料からのｘｉｉｉ因子ポリペプチドの精製
US20060226086A1 (en) * 2005-04-08 2006-10-12 Robinson Thomas C Centrifuge for blood processing systems
EP2385825B1 (en) 2008-11-07 2018-10-10 University of Connecticut Factor viii formulations
ES2740825T3 (es) * 2010-03-30 2020-02-06 Octapharma Ag Un procedimiento de purificación de proteínas dependientes de vitamina K
RU2445974C2 (ru) * 2010-04-26 2012-03-27 Учреждение Российской академии медицинских наук Гематологический научный центр ГНЦ РАМН Способ получения концентрата фактора viii из плазмы крови человека
BR112013011041B1 (pt) 2010-11-05 2021-05-25 Baxalta GmbH variante de fator viii, método para produzir uma variante de fviii, uso da variante de fator viii, e, composição farmacêutica
AU2011343813B2 (en) 2010-12-15 2015-05-21 Takeda Pharmaceutical Company Limited Eluate collection using conductivity gradient
CN103506080A (zh) * 2012-06-19 2014-01-15 汪志友 一种用于分离纯化凝血因子viii的介质及其制备方法
JP6284481B2 (ja) * 2012-09-28 2018-02-28 中外製薬株式会社 血液凝固反応の評価方法
US9663553B2 (en) * 2014-01-29 2017-05-30 Hemarus Therapeutics Limited Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495175A (en) * 1982-08-05 1985-01-22 University Of Rochester Preparation of highly purified human antihemophilic factor
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
DK525384D0 (da) * 1984-11-05 1984-11-05 Nordisk Insulinlab Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat
US4847362A (en) * 1985-02-01 1989-07-11 New York University Method for purifying antihemophilic factor
US4675385A (en) * 1985-03-27 1987-06-23 Alpha Therapeutic Corporation Isolation of human plasma procoagulant protein factor VIII from biological factors
US4758657A (en) * 1985-07-11 1988-07-19 Armour Pharmaceutical Company Method of purifying Factor VIII:C
AT391808B (de) * 1986-11-03 1990-12-10 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion
EP0321835B1 (en) * 1987-12-21 1994-09-28 Miles Inc. Gel filteration of factor VIII
WO1989009784A1 (en) * 1988-04-08 1989-10-19 Commonwealth Serum Laboratories Commission Production of heat-stable factor viii concentrate
ES2042138T3 (es) * 1989-05-24 1993-12-01 Miles Inc. Filtracion en gel del factor viii tratado termicamente.

Also Published As

Publication number Publication date
CA2073012C (en) 1996-03-19
HUT60511A (en) 1992-09-28
DE69017050D1 (de) 1995-03-23
HU9201551D0 (en) 1992-08-28
PL287703A1 (en) 1991-12-02
RU2055593C1 (ru) 1996-03-10
IL96277A (en) 1995-07-31
ES2068404T3 (es) 1995-04-16
DK162233B (da) 1991-09-30
NZ236004A (en) 1991-11-26
WO1991007438A1 (en) 1991-05-30
UA29421C2 (uk) 2000-11-15
EP0524172B1 (en) 1995-02-15
CZ537190A3 (cs) 1998-05-13
DK562189A (da) 1991-05-10
BG61231B1 (en) 1997-03-31
ATE118508T1 (de) 1995-03-15
IL96277A0 (en) 1991-08-16
NO180741C (no) 1997-06-11
NO180741B (no) 1997-03-03
PT95830B (pt) 1997-11-28
SK537190A3 (en) 1997-12-10
BG96316A (bg) 1993-12-24
DE69017050T2 (de) 1995-06-14
YU210590A (sh) 1993-05-28
FI922105A0 (fi) 1992-05-08
FI103510B1 (fi) 1999-07-15
DK162233C (da) 1992-03-16
IE904022A1 (en) 1991-05-22
US5245014A (en) 1993-09-14
PL164894B1 (pl) 1994-10-31
DK562189D0 (da) 1989-11-09
IE66836B1 (en) 1996-02-07
ZA908599B (en) 1991-07-31
JP2509407B2 (ja) 1996-06-19
CN1044121C (zh) 1999-07-14
NO921839D0 (no) 1992-05-08
SK278640B6 (en) 1997-12-10
AU631471B2 (en) 1992-11-26
FI103510B (fi) 1999-07-15
PT95830A (pt) 1991-09-30
NO921839L (no) 1992-07-08
CN1051732A (zh) 1991-05-29
AU6747090A (en) 1991-06-13
CA2073012A1 (en) 1991-05-10
HU214905B (hu) 1998-07-28
JPH05501557A (ja) 1993-03-25
EP0524172A1 (en) 1993-01-27
FI922105A (fi) 1992-05-08

Similar Documents

Publication Publication Date Title
YU47524B (sh) Postupak za izolovanje faktora viii iz drugih proteina u krvnoj plazmi
DE3172567D1 (en) Method of blood plasma fractionation
PT77897A (en) Process for the production of cell lines used for the preparation of proteins and pharmaceutical compositions containing such proteins
MX9702932A (es) L-ribofuranosilnucleosidos.
ATE83151T1 (de) Zellmembranproteine, zubereitungen, die sie enthalten und verfahren zu ihrer herstellung.
DE69635578D1 (de) Verfahren und system zur behandlung dispergierbarer feiner pulver
PH17834A (en) Homogenous human interleukin,pharmaceutical compositions containing the same and process therefor
PT76831B (en) Process for preparing teichomycin a2 pure single factors 1,2,3,4 and 5 and of pharmaceutical compositions containing the same
ES2000030A6 (es) Metodo de purificar factor sanguineo viii:c
HUT52782A (en) Process for isolating polypeptides from spider-poison of hololena curta and for producing pharmaceutical compositions containing them
PT76657B (en) Process for preparing 4-aryl-4-piperidinecarbinols and of pharmaceutical compositions containing the same
MX9702926A (es) L-eritrosilnucleosidos.
IL68678A0 (en) Process for the production of interleukin and its analogous immune regulating factors and pharmaceutical formulations comprising the same
CA1035320A (en) Method and system for separating a liquid suspension of solid particles into fractions of different average characteristics
DE3374943D1 (en) Process for preparation of free flowing particles
AU567503B2 (en) Process and apparatus for the elution of values from solid particles
MX9702927A (es) L-piranosilnucleosidos.
FR2526425B1 (fr) Derives de cycloalcanes, procede pour leur preparation et compositions les contenant
PT77282A (en) Process for preparing substituted 1-pyridyloxy-3-indolylalkylamino-2-propanols and of pharmaceutical compositions containing the same
JPS56125310A (en) Preparation of protein solution consisting essentially of lipoprotein of plasma with high specific gravity and serum albumin
IT1194795B (it) Procedimento per la eliminazione del gruppo n-formile da peptidi n-formilati e da esteri di peptidi n-formilati
PT76389A (en) Process for the preparation of 7-alpha-aminoacyl-3-chlorocepha-losporins having and anti-infections effect and their use for the preparation of pharmaceutical compositions having an anti-infections effect
AU5633680A (en) Compositions and method of treatment using peptides
PT76108B (en) Process for preparing benzodiazepines and of pharmaceutical compositions containing the same
RO103224A2 (en) Elaboration method of silicoalluminium